[1] Wang Y, Zhao X, Liu L, et al.prevalence and outcomes of symptomatic intracranial large artery stenoses and occlusions in China the Chinese Intracranial Atherosclerosis(CICAS)Study[J]. Stroke, 2014, 45(3): 663-669. [2] Jiang M, Liu X, Zhang D, et al.Celastrol treatment protects against acute ischemic stroke-induced brain injury by promoting an IL-33ST2 axis-mediated microgliamacrophage M2 polarization[J]. Journal of Neuroinflammation, 2018, 15(1): 78-79. [3] 王美琴,李东芳,白波,等. 炎症反应在脑梗死中的研究进展[J]. 中华临床医师杂志(电子版),2019,13(12):947-951. [4] Kumar A, Ekavali, Chopra K, et al.Current knowledge and pharmacological profile of berberine: An update[J]. European Journal of pharmacology, 2015, 761: 288-297. [5] 王博,孙亚男,王继燕,等. 小檗碱通过激活通路减轻脑缺血再灌注大鼠炎症及凋亡[J]. 中国动脉硬化杂志,2019,27(10):847-852. [6] 马翠苓,潘旭东,马爱军,等. 大动脉粥样硬化性脑梗死患者趋化因子CXCL16水平与微栓子检测的相关性[J]. 中国脑血管病杂志,2012,9(3):118-122. [7] Liew FY, Pitman NI, McInnes IB. Disease-associated functions of IL-33: the new kid in the IL-1 family[J]. Nature Reviews Immunology, 2010, 10(2): 103-110. [8] Liu J, Xing Y, Gao Y, et al.Changes in serum interleukin-33 levels in patients with acute cerebral infarction[J]. Journal of Clinical Neuroscience, 2014, 21(2): 298-300. [9] 张勇,田仲兰,何改平. 血清CXCL12和IL-33在急性缺血性脑卒中预后评估中的价值[J]. 中国免疫学杂志,2017,33(10):1539-1542. [10] Qian L, Yuanshao L, Wensi H, et al.Serum IL-33 Is a Novel Diagnostic and prognostic Biomarker in Acute Ischemic Stroke[J]. Aging and Disease, 2016, 7(5): 614-622. |